Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression

American Journal of Gastroenterology

Volumn 99, Issue 10, 2004, Pages 1998-2006

  Sarkar, Sanchoy ^a   Thompson, David G ^b   Woolf, Clifford J ^b   Hobson, Anthony R ^b   Millane, Teri ^b   Aziz, Qasim ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLORIC ACID; OMEPRAZOLE; PROTON PUMP INHIBITOR; SODIUM CHLORIDE;

ADULT; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG MEGADOSE; ELECTROSTIMULATION; ESOPHAGUS MANOMETRY; ESOPHAGUS PARAMETERS; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERALGESIA; INFUSION; MALE; NERVE EXCITABILITY; PAIN THRESHOLD; PRIORITY JOURNAL; SENSITIZATION; STOMACH ACID; SYMPTOM; THORAX PAIN; VISCERAL PAIN;

ACIDS; ADULT; CHEST PAIN; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PAIN THRESHOLD; PROTON PUMPS; VISCERA;

EID: 7044253553     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40174.x     Document Type: Article

References (36)

1. Head H. On disturbance of sensation, with reference to pain from visceral diseases. Brain 1893;16:1-133.
2. Richter JE. Overview of diagnostic testing for chest pain of unknown origin. Am J Med 1992;92:41s-45s.
3. Soffer EE, Scalabrini P, Wingate DL. Spontaneous noncardiac chest pain: Value of ambulatory esophageal pH and motility monitoring. Dig Dis Sci 1989;34:1651-5.
4. Ros E, Toledo Pimentel V, Grande L, et al. Thoracic pain of esophageal origin. Assessment of 125 consecutive patients with resting angina and angiographically normal coronary arteries. Med Clin Barc 1996;106:81-6.
5. Gastal OL, Castell JA, Castell DO. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring. Chest 1994;106:1793-6.
6. Yu HK, Tseng CC, Chang CS, et al. Ambulatory 24-hour esophageal manometry and pH-metry in patients with noncardiac chest pain, but no reflux symptoms. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1997;13:293-300.
7. Fass R, Fennerty MB, Johnson C, et al. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol 1999;28:36-9.
8. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997;42:2138-45.
9. Stahl WG, Beton RR, Johnson CS, et al. Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain. South Med J 1994;87:739-42.
10. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:845-52.
11. Treede RD, Meyer RA, Raja SN, et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992;38:397-421.
12. Torebjork HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol Lond 1992;448:765-80.
13. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983;306:686-8.
14. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.
15. Woolf CJ. An overview of the mechanisms of hyperalgesia. Pulm Pharmacol 1995;8:161-7.
16. Sarkar S, Aziz QA, Woolf CJ, et al. Contribution of central sensitisation to the development of noncardiac chest pain. Lancet 2000;356:1154-9.
17. Sarkar S, Hobson AR, Furlong PL, et al. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2001;281:G1196-202.
18. Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology 1958;34:760-81.
19. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277-99.
20. Bland M. An introduction to medical statistics. 2nd ed. Oxford: Oxford Medical Publication, 1995:267-68.
21. Matthews JNS, Altman DG, Campbell MJ, et al. Analysis of serial measurements in clinical research. Br Med J 1990;300:230-235.
22. Altman DG. Practical statistics for medical research. (1st ed.). London: Chapman and Hall, 1991.
23. Nostrant TT. Provocation testing in noncardiac chest pain. Am J Med 1992;92:56s-64s.
24. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9.
25. Waldmann R. Proton-gated cation channels - Neuronal acid sensors in the central and peripheral nervous system. Adv Exp Med Biol 2001;502:293-304.
26. Dai Y, Iwata K, Fukuoka T, et al. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci 2002;22:7737-45.
27. Sugiura T, Tominaga M, Katsuya H, et al. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor I. J Neurophysiol 2002;88:544-8.
28. Graven-Nielsen T, Sergerdahl M, Svensson P, et al. Methods for induction and assessment of pain in humans with clinical and pharmacological examples. In: Kruger L, ed. Methods in pain research. Baton Rouge: CRC Press, 2001:263-289.
29. Woolf CJ. Generation of acute pain: Central mechanisms. Br Med Bull 1991;47:523-33.
30. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 1999;96:7723-30.
31. Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64.
32. Opka K, Morely S, Hobson AR, et al. Psychological responses to episodic chest pain. Eur J Pain 2003;7:521-9.
33. Ilkjaer S, Dirks J, Brennum J, et al. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans. Br J Anaesth 1997;79:600-5.
34. Ilkjaer S, Petersen KL, Brennum J, et al. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth 1996;76:829-34.
35. Ren K, Dubner R. NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw. Neurosci Lett 1993;163:22-6.
36. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.